From antimicrobial to anticancer peptides. A review
Top Cited Papers
Open Access
- 1 January 2013
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 4, 294
- https://doi.org/10.3389/fmicb.2013.00294
Abstract
Antimicrobial peptides (AMPs) are part of the innate immune defense mechanism of many organisms. Although AMPs have been essentially studied and developed as potential alternatives for fighting infectious diseases, their use as anticancer peptides (ACPs) in cancer therapy either alone or in combination with other conventional drugs has been regarded as a therapeutic strategy to explore. As human cancer remains a cause of high morbidity and mortality worldwide, an urgent need of new, selective and more efficient drugs is evident. Even though ACPs are expected to be selective towards tumor cells without impairing the normal body physiological functions, the development of a selective ACP has been a challenge. It is not yet possible to predict antitumor activity based on ACPs structures. ACPs are unique molecules when compared to the actual chemotherapeutic arsenal available for cancer treatment and display a variety of modes of action which in some types of cancer seem to co-exist. Regardless the debate surrounding the definition of structure-activity relationships for ACPs, great effort has been invested in ACP design and the challenge of improving effective killing of tumor cells remains. As detailed studies on ACPs mechanisms of action are crucial for optimizing drug development, in this review we provide an overview of the literature concerning peptides’ structure, modes of action, selectivity and efficacy and also summarize some of the many ACPs studied and/or developed for targeting different solid and hematologic malignancies with special emphasis on the first group. Strategies described for drug development and for increasing peptide selectivity towards specific cells while reducing toxicity are also discussed.Keywords
This publication has 99 references indexed in Scilit:
- Recent development in carbohydrate-based cancer vaccinesCurrent Opinion in Chemical Biology, 2009
- The anticancer activity of lytic peptides is inhibited by heparan sulfate on the surface of the tumor cellsBMC Cancer, 2009
- APD2: the updated antimicrobial peptide database and its application in peptide designNucleic Acids Research, 2008
- Studies on anticancer activities of antimicrobial peptidesBiochimica et Biophysica Acta (BBA) - Biomembranes, 2008
- Apoptosis: A Review of Programmed Cell DeathToxicologic Pathology, 2007
- Human neutrophil peptides 1, 2 and 3 are biochemical markers for metastatic colorectal cancerEuropean Journal of Cancer, 2006
- Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?Nature Reviews Microbiology, 2005
- Self-renewal and solid tumor stem cellsOncogene, 2004
- Inflammation and cancerNature, 2002
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002